human | Q5 |
P2671 | Google Knowledge Graph ID | /g/1xy331sz |
P213 | ISNI | 0000000071894401 |
P12541 | Ludzie Nauki ID (new) | 2YBud41iFzn |
P496 | ORCID iD | 0000-0002-4798-1497 |
P7293 | PLWABN ID | 9810570153405606 |
P3124 | Polish scientist ID | 45626 |
P1153 | Scopus author ID | 7006153261 |
P214 | VIAF ID | 102166747 |
P512 | academic degree | habilitation | Q308678 |
scientific professorship degree | Q55695329 | ||
P166 | award received | Knight of the Order of Polonia Restituta | Q15715250 |
Officer of the Order of Polonia Restituta | Q15715251 | ||
P1477 | birth name | Magdalena Małdyk | |
P27 | country of citizenship | Poland | Q36 |
P185 | doctoral student | Dominika Deborska-Materkowska | Q61090382 |
Olga Tronina | Q97517454 | ||
P69 | educated at | Medical University of Warsaw | Q496351 |
P108 | employer | Medical University of Warsaw | Q496351 |
P734 | family name | Durlik | Q27985399 |
Durlik | Q27985399 | ||
Durlik | Q27985399 | ||
P22 | father | Eugeniusz Małdyk | Q65175634 |
P735 | given name | Magdalena | Q842544 |
Magdalena | Q842544 | ||
Joanna | Q4248351 | ||
Joanna | Q4248351 | ||
P1412 | languages spoken, written or signed | Polish | Q809 |
P463 | member of | International Society of Nephrology | Q6053497 |
Society of Polish Internists | Q7065084 | ||
European Society for Organ Transplantation | Q50036080 | ||
Polish Society of Nephrology | Q53935012 | ||
The Transplantation Society | Q74555971 | ||
P25 | mother | Henryka Małdyk | Q52670117 |
P1559 | name in native language | Magdalena Durlik | |
P106 | occupation | physician | Q39631 |
researcher | Q1650915 | ||
P21 | sex or gender | female | Q6581072 |
P3373 | sibling | Paweł Małdyk | Q61152287 |
P26 | spouse | Marek Durlik | Q20028728 |
Q115185183 | 10th Congress of the Polish Transplantation Society (PTT) |
Q44608598 | 36-month follow-up of 75 renal allograft recipients treated with steroids, tacrolimus, and azathioprine or mycophenolate mofetil |
Q87165016 | A comparison between two tacrolimus-based immunosuppression regimens in renal transplant recipients: 7-year follow-up |
Q42527114 | A matched case-control study on the prognosis of native kidney neoplasia in renal transplant recipients |
Q85089746 | A threat of the Klebsiella pneumoniae carbapenemase-producing strains among transplant recipients |
Q46666532 | Acute, idiopathic, bilateral uveitis with periphlebitis--case report |
Q115185156 | Adherence to treatment among chronically ill ambulatory patients |
Q91274498 | Almost 200 Pancreas Transplantations: A Single-Center Experience |
Q73667824 | An association between fibrinolytic activity and graft function in kidney transplantation recipients |
Q62588862 | Analysis of Distribution of Expanded- and Standard-Criteria Donors and Complications Among Polish Recipients by Kidney Donor Risk Index Value |
Q91274505 | Analysis of Hospitalizations in Simultaneous Pancreas-Kidney Transplant Recipients: A Single-center Experience in Poland |
Q95930782 | Analysis of Susceptibility to Selected Antibiotics in Klebsiella pneumoniae, Escherichia coli, Enterococcus faecalis and Enterococcus faecium Causing Urinary Tract Infections in Kidney Transplant Recipients over 8 Years: Single-Center Study |
Q38022438 | Anemia in solid organ transplantation |
Q46466244 | Antiphospholipid antibodies in renal allograft recipients. |
Q37403256 | Are we taking proper care of living donors? A follow-up study of living kidney donors in Poland and further management proposal |
Q43254730 | Arteriolar hyalinization in implantation kidney biopsies as a predictor of graft function |
Q46824952 | Assessment of cadaveric livers discarded from transplantation. A correlation between clinical and histological parameters. |
Q101467699 | Assessment of haemostasis and impact of fibrinogen supplementation on clot properties using global haemostasis assays in patients on chronic dialysis |
Q43254735 | Assessment of kidneys procured from expanded criteria donors before transplantation |
Q52674071 | Assessment of the Hemostatic Parameters and Platelet Function on Thromboelastometry and Impedance Aggregometry in Hemodialysis Patients Qualified for Kidney Transplantation: Preliminary Report. |
Q86413372 | Association between increased levels of regulatory T cells and soluble human leukocyte antigen G with the prevalence of cancer in kidney transplant recipients |
Q40633497 | Association of MYH9 rs3752462 and rs5756168 Polymorphisms With Transplanted Kidney Artery Stenosis. |
Q59697408 | Association of UDP-glucuronosyltransferase 1A9 (UGT1A9) gene polymorphism with kidney allograft function |
Q33387526 | Atypical calcineurin inhibitor-induced haemolytic uremic syndrome after liver transplantation |
Q79899482 | Bacteria isolated from bile samples of liver recipients in the early period after transplantation: epidemiology and susceptibility of the bacterial strains |
Q41671250 | Bacterial and fungal infections in the early post-transplant period after kidney transplantation: etiological agents and their susceptibility. |
Q41671210 | Bacterial and fungal infections in the early post-transplantation period after liver transplantation: etiologic agents and their susceptibility. |
Q41671203 | Bacterial and fungal infections in the early post-transplantation period after simultaneous pancreas-kidney transplantation: etiological agents and their susceptibility. |
Q84962125 | Bacterial infections in the early period after liver transplantation: etiological agents and their susceptibility |
Q71879429 | Basal and stimulated endocrine metabolic function in recipients of pancreatico-duodenal grafts |
Q35851947 | Biomarkers of delayed graft function as a form of acute kidney injury in kidney transplantation |
Q46966045 | Bisphosphonates are effective prophylactic of early bone loss after renal transplantation. |
Q50165542 | Blood cytokine levels rise even after minor surgical trauma |
Q41671264 | Blood infections in patients treated at transplantation wards of a clinical hospital in Warsaw |
Q31943554 | Body distribution of syngeneic and allogeneic cells from vascularized bone marrow graft. |
Q50858639 | Bone Mineral Density and Bone Turnover Markers Under Bisphosphonate Therapy Used in the First Year After Liver Transplantation. |
Q54455842 | Bone marrow cells transplanted in suspension or in vascularized bone graft repopulate not only bone marrow but also lymphoid organs. |
Q79124638 | C4d complement split product expression in chronic rejection of renal allograft |
Q46966010 | C4d complement split product in diagnosis of immunological activity of chronic allograft nephropathy. |
Q46683391 | C4d-positive renal transplants: single-center clinical outcomes |
Q54457418 | CTX-M and TEM as predominant types of extended spectrum beta-lactamases among Serratia marcescens isolated from solid organ recipients. |
Q84179417 | Calcineurin inhibitor sparing immunosuppressive regimens in kidney allograft recipients |
Q39286930 | Cardiac status of persons qualified for living kidney donation--single-center experience |
Q40633486 | Cardiovascular Risk Evaluated With the Use of Heartscore in Kidney Transplant Recipients-Three Years of Follow-up. |
Q85775392 | Cardiovascular disease and kidney transplantation‑evaluation of potential transplant recipient |
Q87025527 | Cardiovascular evaluation of potential transplant recipient: from non-US perspective |
Q84436770 | Catastrophic antiphospholipid syndrome |
Q74616115 | Cellcept enhances the rate of apoptosis in T cells after renal transplantation |
Q86881885 | Characteristics of potential living kidney donors and recipients: donor disqualification reasons--experience of a Polish center |
Q37862833 | Chlamydia pneumoniae infection and ischemic heart disease in hemodialysis patients |
Q37855399 | Chlamydia pneumoniae infection in patients after kidney transplantation treated with spiramycin. |
Q37862830 | Chlamydia pneumoniae infection: an additional factor for chronic allograft rejection |
Q73279216 | Chronic rejection as a risk factor for deterioration of renal allograft function following pregnancy |
Q77739305 | Clinical course of concomitant Hbv and Hcv infection in renal allograft recipients |
Q46966033 | Clinical glycopeptide-resistant enterococci isolated from patients after solid organ transplantation. |
Q73668889 | Clinical manifestations and diagnosis of cytomegalovirus infection in renal allograft recipients |
Q38740292 | Clinicopathologic correlations of renal pathology in the adult population of Poland. |
Q51774007 | Combined oral contraception in women after renal transplantation. |
Q36837272 | Comparative analysis of immunological reconstitution induced by vascularized bone marrow versus bone marrow cell transplantation |
Q82674326 | Comparison of 1-year patient and graft survival rates between preemptive and dialysed simultaneous pancreas and kidney transplant recipients |
Q90595562 | Comparison of Kidney Transplantation Results From the Same Deceased Donor Between Patients With the First Transplantation and Retransplanted Patients |
Q74339744 | Comparison of antigenemia (pp65) assay and polymerase chain reaction in diagnosis of cytomegalovirus infection in renal transplant recipients treated with ATG |
Q44469506 | Comparison of bacteria isolated from urinary tract infections in patients on transplant versus urologic wards |
Q91655488 | Comparison of metabolic syndrome rates in living-donor and deceased-donor kidney recipients - A three-year follow-up: PS003 |
Q46942520 | Comparison of mycophenolic acid pharmacokinetic parameters in kidney transplant patients within the first 3 months post-transplant. |
Q44491043 | Comparison of peak and trough level monitoring of cyclosporine treatment using two modern cyclosporine preparations. |
Q115185155 | Compound Haplotype Variants in CFH and CD46 Genes Determine Clinical Outcome of Atypical Hemolytic Uremic Syndrome (aHUS)—A Series of Cases from a Single Family |
Q38116333 | Current approaches in national kidney paired donation programs. |
Q94468253 | Cutaneous nocardiosis in a liver transplant recipient - case report |
Q74779230 | Cyclosporine A blood concentration during pregnancy in renal allograft recipients |
Q62588874 | Cyclosporine blood concentration at 2 hours (C2) from drug ingestion as the best single indicator of adequate cyclosporine immunosuppression in renal allograft recipients— a four-year follow-up |
Q71879003 | Cyclosporine pharmacokinetics in renal allograft recipients with diabetes mellitus with Sandimmune and Sandimmune Neoral |
Q44770624 | Cytokines and growth factors serum level and renal allograft function (preliminary report) |
Q90705285 | Cytomegalovirus Disease After Liver Transplant-A Description of a Treatment-Resistant Case: A Case Report and Literature Review |
Q54095119 | DNA from rejecting allografts can be detected in recipient nonlymphoid tissues. |
Q46420370 | DNA released from rejecting organs is an indicator of the degree of graft cellular damage |
Q52596012 | Defective gene expression of the membrane complement inhibitor CD46 in patients with progressive immunoglobulin A nephropathy. |
Q79899487 | Detection of Clostridium difficile in stool samples from patients in the early period after liver transplantation |
Q38194887 | Determining eligibility for and preparation to kidney transplantation of a patient with Lynch syndrome--a case report and literature review. |
Q45930796 | Development and validation of limited sampling strategies for the estimation of mycophenolic acid area under the curve in adult kidney and liver transplant recipients receiving concomitant enteric-coated mycophenolate sodium and tacrolimus. |
Q52585132 | Diagnostic utility of monitoring cytomegalovirus-specific immunity by QuantiFERON-cytomegalovirus assay in kidney transplant recipients. |
Q90720258 | Differences in the Incidence of Pathologic Lesions on the Oral Mucosa in Patients Undergoing Hemodialysis vs Renal Organ Transplant Recipients Subjected to Long-term Pharmacologic Immunosuppressive Therapy |
Q88680557 | Different Relevance of Peripheral, Central or Nighttime Blood Pressure Measurements in the Prediction of Chronic Kidney Disease Progression in Patients with Mild or No-Proteinuria |
Q89983178 | Diffusion Weighted Magnetic Resonance Imaging in the Assessment of Renal Function and Parenchymal Changes in Chronic Kidney Disease: A Preliminary Study |
Q45253807 | Diminished integrin expression on granulocytes from renal allograft recipients |
Q90595516 | Do Anatomical Anomalies Affect the Results of Living Donor Kidney Transplantation? |
Q93168505 | Do We Need Insulin Independence After Islet Transplantation? |
Q44608699 | Do high levels of serum triglycerides in pancreas graft recipients before transplantation promote graft pancreatitis? |
Q59355768 | Does Histopathology of Implanted Kidney According to Banff 07 Help Predict Long-term Transplantation Outcome? |
Q71879412 | Does chronic glucocorticosteroid therapy in pregnant renal allograft recipients affect cortisol levels in neonates? |
Q39518527 | Does the Parathyroidectomy Endanger the Transplanted Kidney? |
Q74339790 | Does the high risk of mortality after segmental pancreas transplantation justify another transplant? |
Q48585615 | Donation and Transplantation of Kidneys Harvested From Deceased Donors Over the Age of 60 Years in the Upper Silesia Region. |
Q73286071 | Donor DNA can be detected in recipient tissues during rejection of allograft |
Q96639257 | Donor Klotho KL-VS Polymorphism Predicts Allograft Glomerulosclerosis and Early Post-Transplant Kidney Function |
Q41671170 | Dramatic recurrence of cancer in a patient who underwent kidney transplantation--case report |
Q39518602 | Drug Susceptibility Assessment in Stenotrophomonas Maltophilia Strains Isolated From the Blood of Organ Transplantation Recipients in a Warsaw Teaching Hospital During 2011 to 2014. |
Q90595512 | Duplicated Ureters in Transplantation-A Single-center, Retrospective Study |
Q40586323 | Dynamic Elastography in Diagnostics of Liver Fibrosis in Patients After Liver Transplantation Due to Cirrhosis in the Course of Hepatitis C. |
Q41671195 | Early complications related to the transplanted kidney after simultaneous pancreas and kidney transplantation |
Q85809111 | Early everolimus-induced pneumonitis in a renal transplant recipient: A case report |
Q43933085 | Early hyperglycemia after allogenic kidney transplantation |
Q73668216 | Early loss of transplanted autologous hepatocytes-lysis by leukocytes in vivo and in vitro |
Q50146212 | Eculizumab in Renal Transplantation: A 2017 Update |
Q62588864 | Effect of Selective Antibiotic Pressure on the MLS-B Phenotype in Methicillin-Resistant Staphylococcus aureus Strains Originating From Patients From Transplantation Wards: 24 Years of Observations |
Q62588865 | Effect of Thrombophilic Factors on Renal Graft Function: A Single-Center Experience |
Q73279513 | Effect of chronic liver disease on clinical outcome in renal allograft recipients |
Q98888675 | Effect of donor non-muscle myosin heavy chain (MYH9) gene polymorphisms on clinically relevant kidney allograft dysfunction |
Q74339728 | Effect of glucocorticoid-free immunosuppressive protocol on serum lipids in renal transplant patients |
Q74339853 | Effect of viral infection on T-cell apoptosis in allograft recipients |
Q40291443 | Efficacy, safety, and pharmacokinetics of simeprevir, daclatasvir, and ribavirin in patients with recurrent hepatitis C virus genotype 1b infection after orthotopic liver transplantation: The Phase II SATURN study |
Q57224826 | Efficiency of preventive treatment of glucocorticoid-induced osteoporosis with 25-hydroxyvitamin D3 and calcium in kidney transplant patients |
Q43992373 | Elevated serum immunoglobulins after steroid withdrawal in renal allograft recipients. |
Q88012239 | Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration as a New Diagnostic Tool for Invasive Pulmonary Mycoses |
Q40586407 | Epidemiological and Drug-Resistance Types of Methicillin-Resistant Staphylococcus Aureus Strains Isolated From Surgical and Transplantation Ward Patients During 2010 to 2011. |
Q62825000 | Erratum to: Risk factors for progression in children and young adults with IgA nephropathy: an analysis of 261 cases from the VALIGA European cohort |
Q43254700 | Etiologic agents of bacteremia in the early period after simultaneous pancreas-kidney transplantation. |
Q43483120 | Etiological agents of bacteremia in the early period after liver transplantation. |
Q41671276 | Evaluation of the prevalence of insertion element IS16 in vancomycin-resistant enterococci strains of Enterococcus faecium isolated from transplantology patients from a Warsaw Hospital between 2010 and 2012. |
Q43805030 | Expression of FasL gene in T cells of renal allograft recipients |
Q92021948 | FRAX prognostic and intervention thresholds in the management of major bone fractures in hemodialysis patients: A two-year prospective multicenter cohort study |
Q58602260 | Factors Affecting Health-Related Quality of Life in Liver Transplant Patients |
Q45742026 | Factors affecting reactivation of Epstein-Barr virus infection after kidney allograft transplantation. |
Q43254720 | Factors predisposing to urinary tract infections in adult kidney allograft recipients with lower urinary tract reconstruction. |
Q78106822 | Fast lymphoid reconstitution after vascularized bone marrow transplantation in lethally irradiated rats |
Q41671163 | Fatal late-onset Pneumocystis pneumonia after rituximab: administration for posttransplantation recurrence of focal segmental glomerulosclerosis--case report |
Q40485223 | Fever, human herpesvirus-6 (HHV-6) seroconversion, and acute rejection episodes as a function of the initial seroprevalence for HHV-6 in renal transplant recipients |
Q39453035 | Fibrosing Cholestatic Hepatitis C After Liver Transplantation: Therapeutic Options Before and After Introduction of Direct-Acting Antivirals: Our Experience and Literature Review. |
Q74094451 | Flow cytometry crossmatch in living donor renal transplantation |
Q103040743 | Formulas Estimating Glomerular Filtration Rate in the Evaluation of Living Kidney Donor Candidates: Comparison of Different Formulas With Scintigraphy-Measured Glomerular Filtration Rate |
Q46966051 | Function of the ovaries in female kidney transplant recipients. |
Q43695272 | Glomerular filtration rate estimation in prospective living kidney donors: preliminary study. |
Q74339831 | Graft infiltrating t-lymphocyte expression of CD26, CD29, and CD49e molecules and genes |
Q94488592 | Hand Hygiene Among Doctors in Transplant Departments in Poland: A Cross-sectional Survey |
Q37633040 | Hand-assisted laparoscopic donor nephrectomy: a single centre experience |
Q74339762 | Hepatocellular carcinoma development in renal allograft recipients |
Q51817326 | High rate of endometrial hyperplasia in renal transplanted women. |
Q95471499 | History of kidney transplantation in Poland |
Q37226755 | Hodgkin-like lymphoma, simulating anaplastic large cell lymphoma in the patient after renal transplantation--unusual case report and literature review |
Q45225286 | Homocysteine and lipid peroxidation products: important atherosclerosis risk factors in renal allograft recipients? |
Q98886057 | Human Papillomavirus (HPV) DNA Detection Using Self-Sampling Devices in Women Undergoing Long Term Immunosuppressive Therapy |
Q51591178 | Human Pooled Immunoglobulin as Treatment of Active Antibody-Mediated Rejection of Transplanted Kidney. |
Q33371467 | Human herpes virus 6 infection in renal transplant recipient--case report |
Q62588872 | Human herpesvirus 6 variant A infection in renal transplant recipient |
Q62588877 | Human herpesvirus-6 and human herpesvirus-8 seroprevalence in kidney transplant recipients |
Q44608613 | Human herpesvirus-6 in renal transplant recipients: potential risk factors for the development of human herpesvirus-6 seroconversion. |
Q82674448 | Human splenic dendritic cells react differently to bacterial and allogeneic antigens |
Q37998907 | Hypertension in solid organ transplant recipients |
Q53816875 | Identification of cytomegalovirus (CMV) infection by different laboratory methods in renal transplant recipients undergoing triple-drug immunosupressive treatment. |
Q43814885 | IgA nephropathy in kidney allograft recipients-therapeutic perspective. |
Q91837466 | Immune Algorithm Optimization for Organ Transplantation in Poland |
Q89327121 | Immune biomarkers and long‑term graft survival: a prospective follow‑up of 457 kidney transplant recipients |
Q115185150 | Immunity after COVID-19 Recovery and Vaccination: Similarities and Differences |
Q44812462 | Immunosuppression in kidney transplantation in Poland. |
Q85930801 | Impact of pretransplant body mass index on early kidney graft function |
Q38284761 | Improvement of graft function following Roux-en-Y gastric bypass surgery in a morbidly obese kidney recipient: a case report and literature review |
Q46812835 | Infectious complications after simultaneous pancreas-kidney transplantation |
Q40586344 | Influence of Double-J Catheters on Urinary Infections After Kidney Transplantation |
Q82674333 | Influence of pancreas and kidney transplant function on recipient survival |
Q83491080 | Influence of preservation method on histopathological lesions of kidney allografts |
Q48222504 | Influence of simultaneous pancreas and preemptive kidney transplantation on severity of postoperative complications |
Q46824956 | Insulin resistance in kidney allograft recipients treated with calcineurin inhibitors |
Q78693317 | Intracellular cytokine production in chronic renal allograft rejection |
Q85352065 | Iron metabolism in solid‑organ transplantation: how far are we from solving the mystery? |
Q93003224 | Is there long-term value of pathology scoring in immunoglobulin A nephropathy? A validation study of the Oxford Classification for IgA Nephropathy (VALIGA) update |
Q115185152 | Kidney and Liver Tissue Tacrolimus Concentrations in Adult Transplant Recipients-The Influence of the Whole Blood and Tissue Concentrations on Efficiency of Treatment during Immunosuppressive Therapy |
Q31144561 | Kidney disease in the elderly: biopsy based data from 14 renal centers in Poland |
Q37653732 | Kidney dysfunction after non renal solid organ transplantation |
Q45328407 | Kidney transplantation does not increase the level of basic hope or life satisfaction compared with hemodialysis in patients with chronic kidney disease |
Q64277503 | Killer Immunoglobulin-Like Receptor 2DS2 (KIR2DS2), KIR2DL2-HLA-C1, and KIR2DL3 as Genetic Markers for Stratifying the Risk of Cytomegalovirus Infection in Kidney Transplant Recipients |
Q73887271 | Kinetics of bone marrow repopulation in lethally irradiated rats after transplantation of vascularized bone marrow in syngeneic hind limb |
Q45201388 | Lamivudine therapy for chronic hepatitis B in renal transplant recipients |
Q35311125 | Laser-Doppler versus fluorometry in the postoperative assessment of a cutaneous free flap |
Q46105800 | Late conversion to everolimus complicated with necrotizing glomerulonephritis in a renal allograft recipient: case report. |
Q44575993 | Left ventricular hypertrophy in renal transplant recipients in the first year after transplantation. |
Q115185161 | Lifestyle risk factors of non-communicable diseases among patients after liver transplantation – a pilot study |
Q64043990 | Liver Transplantation for a Metastatic Pancreatic Solid-Pseudopapillary Tumor (Frantz Tumor): A Case Report |
Q39518566 | Living-Donor Versus Deceased-Donor Kidney Transplantation: Comparison of Psychosocial Consequences for Recipients |
Q47181826 | Long term medical and economical benefit of machine perfusion (MP) kidney storage in comparison to cold storage (CS). |
Q91274502 | Long-term Outcomes in Simultaneous Pancreas-Kidney Transplant Recipients: Single-center Experience From Poland |
Q92401668 | Long-term outcome of renal transplantation: a 10-year follow-up of 765 recipients |
Q44231504 | Long-term results of kidney transplantation from HCV-positive donors. |
Q47842987 | Long-term results of treatment of chronic hepatitis B, C and D with interferon-alpha in renal allograft recipients |
Q115116952 | Long-term results of treatment of chronic hepatitis B, C and D with interferon-α in renal allograft recipients |
Q73278811 | Long-term survival of limb allografts after weaning of cyclosporine: possible role of microchimerism |
Q74094212 | Low-stage renal carcinoma of the native kidneys in renal transplant recipients |
Q71879347 | Lymphocyte adhesion molecules in renal allograft rejection |
Q44646073 | Lymphocyte counts in kidney allograft recipients are associated with IMPDH2 3757T>C gene polymorphism |
Q74339333 | Lymphocyte interactions with extracellular matrix proteins and endothelium in renal allograft recipients |
Q47280482 | Machine perfusion preservation improves renal allograft survival |
Q50470923 | Magnification chromoendoscopy in comparison to standard chromoendoscopy for detection of intestinal metaplasia in renal transplant recipients. |
Q62588867 | Malnutrition Risk in Kidney Recipients Treated With Mycophenolate Mofetil Is Associated With IMPDH1 rs2278294 Polymorphism |
Q36817829 | Management of highly sensitized patients--deceased donor |
Q91814749 | Massive Ascites of Unknown Origin: A Case Report |
Q31943548 | Microchimerism following allogeneic vascularized bone marrow transplantation--its possible role in induction of posttransplantation tolerance. |
Q79899470 | Mode of delivery in women after liver transplantation |
Q41671291 | Molecular analysis of carbapenem-resistant strains of Pseudomonas aeruginosa isolated from patients hospitalized in various transplantation wards between 2008 and 2011. |
Q41671284 | Molecular and phenotypic characteristics of methicillin-resistant Staphylococcus aureus strains isolated from hospitalized patients in transplantation wards |
Q43254686 | Molecular epidemiology of vancomycin-resistant Enterococcus faecalis among patients of transplantology wards |
Q43254683 | Molecular epidemiology of vancomycin-resistant Enterococcus faecium infecting recipients of solid organs in the transplant surgery ward in 2005 and 2006. |
Q115185149 | Molnupiravir Outpatient Treatment for Adults with COVID-19 in a Real-World Setting—A Single Center Experience |
Q43254725 | Multidrug resistance-associated protein 2 gene (ABCC2) variant in kidney allograft recipients. |
Q44779481 | Multiple neoplastic lesions of the lower genital tract in a human papilloma virus-infected kidney-pancreas allograft recipient: a case report. |
Q45362511 | Multiple types of high-risk human papilloma virus in the lower genital tract of a female kidney recipient: a case report |
Q43465704 | Multivariate analysis of complications after simultaneous pancreas and kidney transplantation. |
Q48461706 | N-terminal pro-B-type natriuretic peptide (NT-proBNP) assessment in the first year after renal transplantation and its relationship with graft function and left ventricular hypertrophy. |
Q45325834 | Negative Correlation Between Hepatitis C Virus (HCV) and Let-7 MicroRNA Family in Transplanted Livers: The Role of rs868 Single-Nucleotide Polymorphism |
Q40586351 | Nephropathy Evolving Within the First Two Posttransplant Months With No Typical Cytopathic Lesions: Two Cases Presentation. |
Q73438187 | Nonspecific rapid elimination of transplanted allogeneic bone marrow cells |
Q40631317 | Nursing Problems in Care of a Patient with Very Early HCV Infection Recurrence After Liver Transplantation: A Case Report. |
Q79899562 | Occurrence of glycopeptide-resistant enterococci in transplant medicine internal wards in 2001-2005 |
Q47211118 | One-year results of a prospective, randomized trial comparing two machine perfusion devices used for kidney preservation. |
Q79899435 | Operative treatment of endometrial hyperplasia in kidney graft recipients: report of seven cases |
Q43254722 | Optimal mycophenolic acid and mycophenolic acid glucuronide levels at the early period after kidney transplantation are the key contributors to improving long-term outcomes. |
Q46894263 | Oral and transdermal hormonal contraception in women after kidney transplantation |
Q80440410 | Organ donation in Poland 2006 |
Q80136887 | Organ transplantation at the Medical University of Warsaw |
Q53851214 | P-glycoprotein expression influences the result of 99mTc-MIBI scintigraphy in tertiary hyperparathyroidism. |
Q71879431 | Pancreas transplantation: four vascular anastomoses |
Q40002716 | Participation of strictly anerobic bacteria in infections among hospitalized transplant patients in a clinical hospital in Warsaw. |
Q47681217 | Pathologies in Living Kidney Donors Diagnosed in the Long-Term Care System. |
Q93084861 | Pharmacokinetics of free and total mycophenolic acid in adult lupus nephritis patients-implications for therapeutic drug monitoring |
Q43985914 | Pneumonia in kidney allograft recipients |
Q45475039 | Polyoma BK virus reactivation in kidney and pancreas-kidney recipients. |
Q44608610 | Polyomavirus BK infection. |
Q43552992 | Positive effect of steroid withdrawal on bone mineral density in renal allograft recipients. |
Q62588868 | Posttransplant Lymphoproliferative Disorder in Kidney and Liver Transplant Recipients: A Single-Center Experience |
Q82674150 | Posttransplant lymphoproliferative disorder: morphological picture and diagnostic difficulties |
Q44608626 | Posttransplantation diabetus mellitus under calcineurin inhibitor |
Q46894265 | Posttransplantation glomerulonephritis: risk factors associated with kidney allograft loss. |
Q44477176 | Posttransplantation lymphoproliferative disorder: case report. |
Q122872393 | Predicting Kidney Failure, Cardiovascular Disease and Death in Advanced CKD Patients |
Q77739231 | Predictor of transplanted kidney deterioration following pregnancy--daily urine protein loss or serum creatinine concentration? |
Q93044187 | Predictors of Acute Kidney Injury in Deceased Kidney Donors After Brain Death |
Q95595792 | Preface |
Q95596992 | Preface |
Q57149791 | Pregnancy in a patient with hepatic artery thrombosis after liver transplantation: a case report |
Q47180325 | Preservation of kidneys by machine perfusion influences gene expression and may limit ischemia/reperfusion injury |
Q36373745 | Prevalence of high-risk human papillomavirus cervical infection in female kidney graft recipients: an observational study |
Q45712768 | Prevalence of the coronary artery disease risk factors and 10-year risk of cardiovascular mortality based on HeartScore in people qualified for kidney donation |
Q80502405 | Primary kidney allograft dysfunction due to myeloma-cast nephropathy: a case report |
Q67428615 | Problems of nephrooncology. Proceedings from the 1st Scientific and Training Conference Nephrooncology 5-6 October 2018, Gdańsk, Poland. |
Q94365767 | Professor Bolesław Rutkowski's 70th birthday Laudatio |
Q85930715 | Profiles of all 550 procurements and transplantations of kidneys from living donors in Poland, 1967-2012 |
Q46966084 | Proinsulinemia in simultaneous pancreas and kidney transplant recipients |
Q90595496 | Psychological Aspects of Living Kidney Donation in Poland: Experience of One Center |
Q95486510 | Pulmonary embolism with septicemia after N-butyl-2-cyanoacrylate injection for bleeding gastric varices |
Q96764484 | Pure Red Cell Aplasia Related to Parvovirus B19 Infection in Simultaneous Pancreas and Kidney Recipient: A Case Report |
Q50767567 | Quality of life after liver transplantation--preliminary report. |
Q46812831 | Quality of life after simultaneous pancreas-kidney transplantation. |
Q73730326 | Quantitative detection of CMV DNA by PCR and hybridizaton methods in renal transplant recipients |
Q86025081 | Rapid normalization of severe hypercholesterolemia mediated by lipoprotein X after liver transplantation in a patient with cholestasis - a case report |
Q40254031 | Real-World Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir/+Dasabuvir±Ribavirin (OBV/PTV/r/+DSV±RBV) Therapy in Recurrent Hepatitis C Virus (HCV) Genotype 1 Infection Post-Liver Transplant: AMBER-CEE Study |
Q50615643 | Recipient uridine 5'-diphospho-glucuronosyltransferase UGT1A9 c.98T>C variant determines transplanted kidney filtration rate. |
Q31943535 | Reconstitution of lymphoid tissue after vascularized bone marrow transplantation. |
Q91274509 | Reconstruction of Multiple Renal Arteries During Simultaneous Pancreas and Kidney Transplantation: A Case Report |
Q74094220 | Regulators of fibrynolysis in plasma of kidney transplant recipients |
Q40633528 | Renal Transplantation Using Kidneys Procured From Elderly Donors Older Than 70 Years |
Q40633383 | Renal Tumor in Allogeneic Kidney Transplant Recipient |
Q72603263 | Renal allograft function in patients with chronic viral hepatitis B and C treated with interferon alpha |
Q44775893 | Renin-Angiotensin-Aldosterone system inhibitors and statins prolong graft survival in post-transplant glomerulonephritis. |
Q74616609 | Requirement of stromal cells in the bone marrow transplant for rapid lymphoid replenishment |
Q62588870 | Resistance to Aminoglycosides of Methicillin-Resistant Strains of Staphylococcus aureus, Originating in the Surgical and Transplantation Wards of the Warsaw Clinical Center—A Retrospective Analysis |
Q43254685 | Resistance to carbapenems among Pseudomonas aeruginosa isolated from patients of transplant wards |
Q95467657 | Response |
Q90595520 | Results of Transplantation of Kidneys Procured From Donors After Brain Death Aged 60 Years and Older |
Q42637323 | Results of a 6-month, multicenter, open-label, prospective study concerning efficacy and safety of mycophenolate sodium in de novo kidney transplant recipients |
Q71879371 | Results of kidney transplantation in HBsAG and anti-HCV seropositive renal allograft recipients |
Q39457194 | Risk factors for progression in children and young adults with IgA nephropathy: an analysis of 261 cases from the VALIGA European cohort. |
Q71111108 | Risk of chronic liver disease in HBsAG and/or anti-HCV-positive renal allograft recipients |
Q90595460 | Role of Transforming Growth Factor-β in Hypertensive Living Kidney Donors |
Q40910315 | Role of adhesion molecules in chronic allograft rejection |
Q62588878 | SP368RENAL DISEASE IN ELDERLY: DATA FROM 14 LARGE NEPHROLOGICAL CENTERS IN POLAND |
Q46698260 | Safety and efficacy of high dose ATG bolus administration on rewascularization in kidney graft patients--long term results. |
Q46966056 | Safety and efficacy of hormonal therapy in menopausal kidney-allograft recipients. |
Q43254723 | Safety and tolerance of sodium mycophenolate in patients after renal transplantation--an observational study. |
Q79198647 | Secondary kidney transplantation in a patient 16 years after simultaneous pancreas and kidney transplantation--a case report |
Q46894238 | Serratia marcescens isolated in 2005 from clinical specimens from patients with diminished immunity. |
Q43254713 | Serum concentration of vitamin D and parathyroid hormone after living kidney donation |
Q40163447 | Severe cytomegalovirus infection in a second kidney transplant recipient treated with ganciclovir, leflunomide, and immunoglobulins, with complications including seizures, acute HCV infection, drug-induced pancytopenia, diabetes, cholangitis, and mu |
Q93062037 | Should Immunosuppression After Kidney Transplant Be Adjusted Based on Renal Resistance During Pretransplant Hypothermic Machine Perfusion? |
Q62588871 | Significance of Screening Tests and the Incidence of New Delhi Metallo-beta-lactamase-Producing Gram-negative Bacilli in the Surgery and Transplantation Wards of a Warsaw Medical Center During the Period From April 2014 to May 2017 |
Q52900614 | Single center experience of subclinical rejections and BK nephropathies by kidney allografts' surveillance biopsies. |
Q41671270 | Specific character of anaerobic bacterial infections in patients treated in transplantation wards at one of the clinical hospitals in Warsaw |
Q43992370 | Steroid withdrawal after renal transplantation--risks and benefits |
Q104067269 | Still diagnosed too late and under-recognized? A first comprehensive report on primary hyperoxaluria from Poland |
Q85089740 | Strains of Klebsiella pneumoniae producing extended spectrum beta-lactamases, isolated from organ recipients |
Q39863324 | Structure of Post-Transplant Care in a Single Transplant Center. |
Q90705175 | Successful Pediatric Kidney Transplantation Into an Adult Recipient: A Case Report |
Q48277019 | Successful outcome of transplant of kidneys recovered from a brain-dead liver transplant recipient: case report |
Q64121233 | Successful transplantation of kidneys from deceased donors with terminal acute kidney injury |
Q40633447 | Surgical Complications Not Related to the Renal and Pancreatic Grafts After Simultaneous Kidney and Pancreas Transplantation. |
Q44665346 | Surgical complications observed in simultaneous pancreas-kidney transplantation: thirteen years of experience of one center |
Q46812828 | Surgical complications of simultaneous pancreas-kidney transplantation: a 16-year-experience at one center. |
Q41671186 | Surgical complications related to transplanted pancreas after simultaneous pancreas and kidney transplantation |
Q43840171 | Surgical implantation of a mechanical valve prosthesis due to aortic stenosis in a patient after liver transplantation: case report |
Q79899475 | Surgical site infections in liver recipients in the early posttransplantation period: etiological agents and susceptibility profiles |
Q51802922 | Surgical site infections in the early posttransplant period after simultaneous pancreas-kidney transplantation. |
Q47972504 | Surgical trauma evokes a rise in the frequency of hematopoietic progenitor cells and cytokine levels in blood circulation |
Q77177323 | T-cell apoptosis following renal transplantation |
Q41129371 | T-cell interactions with extracellular matrix proteins and endothelium in chronic renal allograft rejection |
Q36735516 | The Comparison of the Podocyte Expression of Synaptopodin, CR1 and Neprilysin in Human Glomerulonephritis: Could the Expression of CR1 be Clinically Relevant? |
Q74094438 | The T-cell apoptosis in the early period after renal allograft transplantation |
Q44179521 | The assessment of residual kidney function after living donor nephrectomy |
Q83094217 | The calcium-sensing receptor and vitamin D receptor expression in tertiary hyperparathyroidism |
Q51807077 | The current management of kidney disease in the elderly. |
Q53143936 | The dominant sequence types of vancomycin-resistant Enterococcus faecium among transplantation ward patients. |
Q83482834 | The early and long term function and survival of kidney allografts stored before transplantation by hypothermic pulsatile perfusion. A prospective randomized study |
Q44131711 | The effect of chronic allograft rejection on plasma regulators of fibrinolysis. |
Q38676026 | The effect of the use of a TNF-alpha inhibitor in hypothermic machine perfusion on kidney function after transplantation. |
Q42874454 | The efficacy and safety of ciclosporin (Equoral®) capsules after renal transplantation: A multicentre, open-label, phase IV clinical trial. |
Q38364839 | The first Polish liver transplantation after Roux-en-Y gastric bypass surgery for morbid obesity: a case report and literature review. |
Q90776289 | The genetic architecture of membranous nephropathy and its potential to improve non-invasive diagnosis |
Q89716547 | The impact of the recipient and donor interferon lambda-3 polymorphism on the course of HCV infection following liver transplantation |
Q46894286 | The influence of immuosuppressive therapy on the development of CD4+CD25+ T cells after renal transplantation. |
Q44770629 | The influence of lamivudine therapy on the course of chronic hepatitis B in renal allograft recipients |
Q73438073 | The kinetics of seeding of syngeneic cells from vascularized bone marrow grafts |
Q30371025 | The methods of therapy ESRD patients infected with the human immunodeficiency virus-HIV |
Q89851400 | The molecular diagnosis of rejection in liver transplant biopsies: First results of the INTERLIVER study |
Q117069557 | The molecular phenotypes of injury, steatohepatitis, and fibrosis in liver transplant biopsies in the INTERLIVER study |
Q44608602 | The role of the protocol biopsies in renal allograft recipients |
Q50906356 | The significance of antiphospholipid antibodies in liver recipients. |
Q96687950 | The switch from proteasome to immunoproteasome is increased in circulating cells of patients with fast progressive immunoglobulin A nephropathy and associated with defective CD46 expression |
Q92623595 | The use of anticoagulants in chronic kidney disease: Common point of view of cardiologists and nephrologists |
Q43860157 | The usefulness of hyperimmune globulin for treatment of overt cytomegalovirus infection in allograft recipients |
Q44770627 | The usefulness of tubular and glomerular proteinuria measurement in non-invasive diagnosis of vascular changes accompanying chronic allograft nephropathy |
Q46966005 | The weight of pharmacokinetic parameters for mycophenolic acid in prediction of rejection outcome: the receiver operating characteristic curve analysis |
Q92418237 | Therapeutic Problems and Pregnancy in a Patient With Infantile Nephropathic Cystinosis: A Case Report |
Q82674368 | Thrombotic nephropathy and pulmonary hypertension following autologous bone marrow transplantation in a patient with acute lymphoblastic leukemia: case report |
Q93034353 | Time of Cold Storage Prior to Start of Hypothermic Machine Perfusion and Its Influence on Graft Survival |
Q32054243 | Tolerance induction following allogeneic vascularized bone marrow transplantation--the possible role of microchimerism |
Q85089616 | Tolerance of enteric-coated mycophenolate sodium in combination with calcineurin inhibitor in kidney transplant recipients: Polish experience |
Q83401631 | Transplant glomerulopathy: clinical and pathological correlations |
Q68570236 | Transplantation of bone marrow with vascularized bone |
Q79124747 | Transplantation of hepatocytes: elimination of recipient natural killer cells with irradiation and bone marrow reconstitution prevent early graft dysfunction |
Q81610493 | Transplantation of hepatocytes: temporary elimination of scavenger cells prevents early loss of grafted cells |
Q43030546 | Transplantation of kidneys from Anti-HCV positive donors. |
Q68188510 | Transplantation of vascularized bone marrow |
Q40633471 | Treatment of Persistent Hypercalcemia and Hyperparathyroidism With Cinacalcet After Successful Kidney Transplantation |
Q73677676 | Treatment of chronic hepatitis B and C with interferon-alpha in renal allograft recipients: preliminary results |
Q74339772 | Treatment of chronic hepatitis B with lamivudine in renal allograft recipients |
Q96773894 | Treatment of recurrent urinary tract infections in a 60-year-old kidney transplant recipient. The use of phage therapy |
Q46452909 | Tubular and glomerular proteinuria in diagnosing chronic allograft nephropathy with relevance to the degree of urinary albumin excretion. |
Q45993586 | Uridine diphosphate glucuronosyltransferase 2B7 variant p.His268Tyr as a predictor of kidney allograft early acute rejection. |
Q89860453 | Urinary MicroRNA-21-5p as Potential Biomarker of Interstitial Fibrosis and Tubular Atrophy (IFTA) in Kidney Transplant Recipients |
Q40586362 | Urinary Tract Infections in Kidney Transplant Recipients Hospitalized at a Transplantation and Nephrology Ward: 1-Year Follow-up. |
Q92469250 | Urinary levels of CCL2 and CXCL10 chemokines as potential biomarkers of ongoing pathological processes in kidney allograft: an association with BK virus nephropathy |
Q43517371 | Urinary tract infections in the early posttransplant period after kidney transplantation: etiologic agents and their susceptibility. |
Q51000752 | Urinary tract infections in the early posttransplant period after liver transplantation: etiologic agents and their susceptibility. |
Q51802915 | Urinary tract infections in the early posttransplant period after simultaneous pancreas-kidney transplantation. |
Q74094159 | Use of daclizumab in the immunosuppression of high-risk kidney and kidney/pancreas recipients: Warsaw Transplantation Center experience |
Q43254728 | Use of high-dose human immune globulin in highly sensitized patients on the kidney transplant waiting list: one center's experience |
Q52982735 | Usefulness of Modified Dindo-Clavien Scale to Evaluate the Correlation Between the Severity of Surgical Complications and Complications Related to the Renal and Pancreatic Grafts After Simultaneous Kidney and Pancreas Transplantation. |
Q73887276 | Usefulness of hybridization and PCR methods in monitoring of CMV infection in renal transplant recipients |
Q90587588 | Viruses in transplantology |
Q36450557 | What is new in clinical kidney and liver transplantation. |
Q51102449 | When less is more--case report of successful renal transplantation from a living unrelated donor to a high-risk female recipient. |
Q83172906 | [Cardiovascular risk factors and their modification after renal transplantation] |
Q72392274 | [Chronic peritoneal dialysis in treatment of irreversible chronic failure complicating diabetic nephropathy] |
Q76375486 | [Complement split product C4 as the indicator of immunological activity in chronic allograft rejection] |
Q68111805 | [Effect of long-term administration of 25-hydroxycholecalciferol on the regeneration of compact and spongy bone tissue in dogs receiving prednisone] |
Q73369331 | [Evaluation of the usefulness of various PCR method variations and nucleic acid hybridization for CMV infection in immunosuppressed patients] |
Q81315522 | [Immunossupresive drugs in renal transplantation] |
Q74075209 | [Kidney or kidney and pancreas transplantation in patients with diabetic nephropathy] |
Q71124555 | [Personal experience with simultaneous transplantation of pancreas segment and kidney] |
Q83571672 | [Polish multicenter study on safety and efficacy of adefovir dipivoxil in the treatment of lamivudine resistant chronic hepatitis B in adults (HEP 2008)] |
Q83942081 | [Polyoma virus BK nephropathy in kidney allograft recipients] |
Q69931234 | [Prostaglandins in experimental vasorenal hypertension] |
Q68551510 | [Rare tumor of the small intestine (leiomyoblastoma)] |
Q69163344 | [Stress-induced gastric and duodenal ulcers] |
Q73737545 | [The effect of hypolipidemia treatment on the function of kidney transplanted from cadavers] |
Q72701631 | [Tuberculosis in patients after kidney transplantation] |
Q20028728 | Marek Durlik | spouse | P26 |
Q61152287 | Paweł Małdyk | sibling | P3373 |
Magdalena Durlik | wikipedia |
Search more.